Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Current Deferred Revenue (2020 - 2025)

Historic Current Deferred Revenue for GoHealth (GOCO) over the last 6 years, with Q3 2025 value amounting to $29.2 million.

  • GoHealth's Current Deferred Revenue fell 3162.12% to $29.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.2 million, marking a year-over-year decrease of 3162.12%. This contributed to the annual value of $53.7 million for FY2024, which is 251.32% up from last year.
  • GoHealth's Current Deferred Revenue amounted to $29.2 million in Q3 2025, which was down 3162.12% from $33.4 million recorded in Q2 2025.
  • GoHealth's 5-year Current Deferred Revenue high stood at $114.2 million for Q3 2022, and its period low was $536000.0 during Q4 2021.
  • Moreover, its 5-year median value for Current Deferred Revenue was $27.8 million (2024), whereas its average is $29.9 million.
  • In the last 5 years, GoHealth's Current Deferred Revenue tumbled by 9898.75% in 2021 and then skyrocketed by 2025311.94% in 2022.
  • Over the past 5 years, GoHealth's Current Deferred Revenue (Quarter) stood at $536000.0 in 2021, then soared by 9339.18% to $50.6 million in 2022, then grew by 3.58% to $52.4 million in 2023, then grew by 2.51% to $53.7 million in 2024, then tumbled by 45.65% to $29.2 million in 2025.
  • Its Current Deferred Revenue stands at $29.2 million for Q3 2025, versus $33.4 million for Q2 2025 and $23.7 million for Q1 2025.